Education
About Us
Working with TipRanks
Follow Us
Zimmer Biomet Holdings (ZBH)
NYSE:ZBH
ZBH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$97.69 - $129.50
Previous CloseN/A
Volume487.31K
Average Volume (3M)1.88M
Market Cap
$21.37B
Enterprise Value$26.99B
Total Cash (Recent Filing)$821.20M
Total Debt (Recent Filing)$1.13B
Price to Earnings (P/E)24.2
Beta0.58
Next Earnings
May 06, 2025EPS Estimate
1.77Last Dividend Ex-Date
Mar 31, 2025Dividend Yield0.92%
Share Statistics
EPS (TTM)4.44
Shares Outstanding199,063,170
10 Day Avg. Volume1,633,218
30 Day Avg. Volume1,879,520
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)N/A
Price to Sales (P/S)2.87
Price to Cash Flow (P/CF)10.90
P/FCF Ratio9.90
Enterprise Value/Market Cap1.26
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.92
Enterprise Value/Ebitda11.14
Forecast
1Y Price Target
$121.35Price Target Upside18.06% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
---
Bulls Say, Bears Say
Bulls Say
Market ExpansionZimmer Biomet aims to expand into other healthcare areas to broaden its market reach beyond its current orthopedic concentration.
Mergers And AcquisitionsThe acquisition being immediately growth accretive helps ZBH leverage its business further to higher-growth end markets/segments.
Product InnovationZimmer Biomet's strategy leverages innovations like Persona knees and Oxford Partial to drive near-term hip and knee market share gains.
Bears Say
Competitive PerformanceZBH's 4Q results largely matched expectations, though the US Ortho performance lagged a key competitor (SYK).
Diversification ImpactZBH’s acceleration of growth through diversification is dilutive to earnings and will take time.
Earnings GuidanceInitial 2025 guidance for adjusted EPS growth is below consensus expectations.
---
Ownership Overview
0.13% Insiders
36.21% Mutual Funds
24.14% Other Institutional Investors
13.13% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ZBH FAQ
What was Zimmer Biomet Holdings’s price range in the past 12 months?
Zimmer Biomet Holdings lowest stock price was $97.69 and its highest was $129.50 in the past 12 months.
What is Zimmer Biomet Holdings’s market cap?
Zimmer Biomet Holdings’s market cap is $21.37B.
When is Zimmer Biomet Holdings’s upcoming earnings report date?
Zimmer Biomet Holdings’s upcoming earnings report date is May 06, 2025 which is in 27 days.
How were Zimmer Biomet Holdings’s earnings last quarter?
Zimmer Biomet Holdings released its earnings results on Feb 06, 2025. The company reported $2.31 earnings per share for the quarter, beating the consensus estimate of $2.295 by $0.015.
Is Zimmer Biomet Holdings overvalued?
According to Wall Street analysts Zimmer Biomet Holdings’s price is currently Undervalued.
Does Zimmer Biomet Holdings pay dividends?
Zimmer Biomet Holdings pays a Quarterly dividend of $0.239 which represents an annual dividend yield of 0.92%. See more information on Zimmer Biomet Holdings dividends here
What is Zimmer Biomet Holdings’s EPS estimate?
Zimmer Biomet Holdings’s EPS estimate is 1.77.
How many shares outstanding does Zimmer Biomet Holdings have?
Zimmer Biomet Holdings has 199,063,170 shares outstanding.
What happened to Zimmer Biomet Holdings’s price movement after its last earnings report?
Zimmer Biomet Holdings reported an EPS of $2.31 in its last earnings report, beating expectations of $2.295. Following the earnings report the stock price went down -5.138%.
Which hedge fund is a major shareholder of Zimmer Biomet Holdings?
Currently, no hedge funds are holding shares in ZBH
---
Zimmer Biomet Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$121.35 (18.06% Upside)
$121.35 (18.06% Upside)
Blogger Sentiment
Bullish
ZBH Sentiment 83%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 2.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $150.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 5.2%
Last 30 Days ▼ 5.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-16.93%
12-Months-Change
Fundamentals
Return on Equity
7.24%
Trailing 12-Months
Asset Growth
-0.61%
Trailing 12-Months
Company Description
Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc. is a global medical technology company that specializes in designing, manufacturing, and marketing orthopedic reconstructive products, including joint replacements, dental implants, and other musculoskeletal products. The company operates in sectors such as orthopedics, sports medicine, and biologics, providing innovative solutions to improve the quality of life for patients worldwide.
---
ZBH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view, highlighting consistent revenue growth, strategic acquisitions, and strong performance in the S.E.T. segment, but also noting challenges such as ERP issues and FX headwinds impacting margins.Read More>---
ZBH Net sales Breakdown
57.81% U.S.
42.19% International
---
ZBH Stock 12 Month Forecast
Average Price Target
$121.35
▲(18.06% Upside)
Technical Analysis
Boston Scientific
―
Strata Skin Sciences
―
Smith & Nephew Snats
―
Stryker
―
Globus Medical
―
Best Analysts Covering ZBH
1 Year
1 Year Success Rate
30/45 ratings generated profit
1 Year Average Return
+5.47%
assigned a buy rating 5 months ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +5.47% per trade.
---